ProMIS Neurosciences Appoints Ivana Rubino as Chief Commercial Officer
PUBLIC · PMNOct 06, 2026
Position
Chief Commercial Officer
Company
ProMIS Neurosciences
Ivana Rubino, Ph.D.
TorontoBiotechnology
Description
ProMIS Neurosciences Inc. announced the appointment of Ivana Rubino, Ph.D., as Chief Commercial Officer, effective October 5, 2026. Dr
Company Information
Company
ProMIS Neurosciences
Location
1920 Yonge St., Suite 200
Toronto, Ontario, Canada
About
ProMIS Neurosciences is a clinical-stage biotechnology company committed to the discovery and development of therapeutic antibodies selective for toxic oligomers associated with the development and progression of neurodegenerative and other misfolded protein diseases. The Company’s proprietary target discovery engine, EpiSelect™, predicts novel targets known as Disease Specific Epitopes (DSEs) on the molecular surface of misfolded proteins that cause neurodegenerative and other misfolded protein diseases, including Alzheimer’s disease (AD), amyotrophic lateral sclerosis (ALS), frontotemporal dementia (FTD), multiple system atrophy (MSA), and Parkinson’s Disease (PD).
Fundz sees it the moment ProMIS Neurosciences changes its leadership, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
TorontoBiotechnology